Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

China Nuokang Bio-Pharmaceutical Inc. (NKBP) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/20/2013 15-12B Form 15-12B - Securities registration termination [Section 12(b)]
02/20/2013 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
02/13/2013 SC 13G/A AMERIPRISE FINANCIAL INC reports a 0.7% stake in China Nuokang Bio-Pharmaceutical Inc.
02/07/2013 SC 13E3/A Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
01/29/2013 SC 13E3/A Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
01/18/2013 SC 13E3/A Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
01/15/2013 SC 13E3/A Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
01/15/2013 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
12/17/2012 SC 13E3/A Form SC 13E3 - Going private transaction by certain issuers [amend]
12/17/2012 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
11/27/2012 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
11/27/2012 SC 13E3/A Form SC 13E3 - Going private transaction by certain issuers [amend]
11/13/2012 SC 13E3/A Form SC 13E3 - Going private transaction by certain issuers [amend]
09/28/2012 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
09/27/2012 GN China Nuokang Bio-Pharmaceutical Inc. Enters Into Definitive Agreement for Going Private Transaction
08/23/2012 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
08/22/2012 GN China Nuokang Bio-Pharmaceutical Inc. Reports Second Quarter 2012 Financial Results
08/01/2012 GN China Nuokang Bio-Pharmaceutical Inc. to Report Second Quarter 2012 Financial Results
06/18/2012 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
06/15/2012 GN China Nuokang Bio-Pharmaceutical Inc. Announces Change in CFO
06/08/2012 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals
06/05/2012 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
06/04/2012 GN China Nuokang Bio-Pharmaceutical Inc. Appoints Lazard and Houlihan Lokey as Independent Financial Advisors to Evaluate "Going Private" Proposal
05/23/2012 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
05/23/2012 GN China Nuokang Bio-Pharmaceutical Inc. Reports First Quarter 2012 Financial Results
05/22/2012 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
05/21/2012 GN China Nuokang Bio-Pharmaceutical Inc. Forms Independent Committee and Appoints Independent Legal Counsel to Evaluate "Going Private" Proposal
05/15/2012 20-F/A Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
04/24/2012 20-F Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
03/16/2012 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
03/14/2012 GN CORRECTING and REPLACING -- China Nuokang Bio-Pharmaceutical Inc. Reports Fourth Quarter and Full Year 2011 Financial Results
03/14/2012 GN China Nuokang Bio-Pharmaceutical Inc. Reports Fourth Quarter and Full Year 2011 Financial Results
02/29/2012 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
02/27/2012 GN China Nuokang Bio-Pharmaceutical Inc. to Report Fourth Quarter and Full Year 2011 Financial Results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy